Novo Nordisk
NVO
NVO
580 hedge funds and large institutions have $9.18B invested in Novo Nordisk in 2019 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 171 increasing their positions, 204 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.2% more ownership
Funds ownership: 18.15% → 18.35% (+0.2%)
16% less repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 204
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Holders
580
Holding in Top 10
10
Calls
$58.1M
Puts
$23.1M
Top Buyers
| 1 | +$49M | |
| 2 | +$44.1M | |
| 3 | +$34M | |
| 4 |
Renaissance Technologies
New York
|
+$31.4M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$28M |
Top Sellers
| 1 | -$44.1M | |
| 2 | -$27.7M | |
| 3 | -$26.6M | |
| 4 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$25.1M |
| 5 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$21.4M |